Frontline Workers & The Elderly Likely To Get Vaccine First If There’s Not Enough For Everyone

On 22 Aug, Ministry of Health’s director of medical services Kenneth Mak said the vaccine for Covid-19 may not be available in large quantities at the beginning.

He pointed out that there “will be many countries” who want the vaccine and companies need to make sure that as many of them get it as possible.

So if there’s really not enough for everyone, the task force will have to prioritise.

Frontline Workers & The Elderly Likely To Get Vaccine First If There’s Not Enough For Everyone

Currently, the task force has two priority groups in mind.

The first is the elderly in Singapore, the most vulnerable group to the Covid-19 pandemic since they have the highest risk of death when infected.

The second will likely be the frontline workers caring for Covid-19 cases.

Other than that, they have no other priority groups at the moment.

He said this in response to the question of whether the vaccine will be made ‘mandatory’ for everyone living in Singapore.

Nothing Is Set In Stone Yet

However, Health Minister Gan Kim Yong said, there is another factor that has to be taken into account: the type of vaccine produced.

Pointing out that currently, there are 30 vaccines undergoing clinical trials globally and another 139 undergoing pre-clinical trials, every vaccine requires a different dosage and method of administration.

Some will have administration methods and dosage that are more suitable for certain groups, and woefully unsuitable for others.

This means that if a vaccine is ready to be administered, it also depends on which group the vaccine is suitable for.

At this point in time, it’s too early to tell.

We Are Pursuing All Avenues

The Task Force assures that they are doing all they can to pursue all sorts of avenues on the vaccine front.

Singapore is also heavily involved in the World Health Organisation’s (WHO) Covax Facility, or ACT Accelerator, which promises Covid-19 technology to all despite their financial status.

There are also several more contracts for vaccines signed but details cannot be mentioned due to agreements of confidentiality.